chr7-100219936-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000317271.3(PVRIG):c.26C>T(p.Ala9Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000703 in 1,550,372 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000317271.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CASTOR3P | NR_028040.1 | n.913+2661G>A | intron_variant, non_coding_transcript_variant | ||||
PVRIG | NM_001397246.1 | upstream_gene_variant | ENST00000699088.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CASTOR3P | ENST00000649671.1 | n.775+3634G>A | intron_variant, non_coding_transcript_variant | ||||||
PVRIG | ENST00000699088.1 | upstream_gene_variant | NM_001397246.1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152260Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000159 AC: 25AN: 157132Hom.: 0 AF XY: 0.000169 AC XY: 14AN XY: 82808
GnomAD4 exome AF: 0.0000694 AC: 97AN: 1398112Hom.: 0 Cov.: 30 AF XY: 0.0000740 AC XY: 51AN XY: 689642
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152260Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74390
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2023 | The c.26C>T (p.A9V) alteration is located in exon 2 (coding exon 1) of the PVRIG gene. This alteration results from a C to T substitution at nucleotide position 26, causing the alanine (A) at amino acid position 9 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at